Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective

Journal of Allergy and Clinical Immunology

Volumn 139, Issue 1, 2017, Pages 173-181.e8

  Vickery, Brian P ^a   Berglund, Jelena P ^b   Burk, Caitlin M ^a   Fine, Jason P ^a   Kim, Edwin H ^a   Kim, Jung In ^a   Keet, Corinne A ^c   Kulis, Michael ^a   Orgel, Kelly G ^a   Guo, Rishu ^a   Steele, Pamela H ^a   Virkud, Yamini V ^d   Ye, Ping ^a   Wright, Benjamin L ^e   Wood, Robert A ^c   Burks, A Wesley ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e MAYO CLINIC   (United States)

Author keywords

desensitization; early intervention; Oral immunotherapy; peanut allergy; randomized clinical trial; sustained unresponsiveness

Indexed keywords

IMMUNOGLOBULIN E; PEANUT EXTRACT; ALLERGEN; PLANT ANTIGEN; PLANT PROTEIN;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EARLY INTERVENTION; EOSINOPHILIC ESOPHAGITIS; FEASIBILITY STUDY; FEMALE; HUMAN; IMMUNE RESPONSE; INFANT; INTENTION TO TREAT ANALYSIS; LOW DRUG DOSE; MAINTENANCE DRUG DOSE; MALE; ORAL IMMUNOTHERAPY; PEANUT ALLERGY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; ARACHIS; BLOOD; DESENSITIZATION; IMMUNOLOGY; PEANUT HYPERSENSITIVITY;

ALLERGENS; ANTIGENS, PLANT; ARACHIS; CHILD, PRESCHOOL; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULIN E; INFANT; MALE; PEANUT HYPERSENSITIVITY; PLANT PROTEINS;

EID: 84994378291     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2016.05.027     Document Type: Article

References (43)

1. 1 Sicherer, S.H., Munoz-Furlong, A., Godbold, J.H., Sampson, H.A., US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J Allergy Clin Immunol 125 (2010), 1322–1326.
2. 2 Osborne, N.J., Koplin, J.J., Martin, P.E., Gurrin, L.C., Lowe, A.J., Matheson, M.C., et al. Prevalence of challenge-proven IgE-mediated food allergy using population-based sampling and predetermined challenge criteria in infants. J Allergy Clin Immunol 127 (2011), 668–676 e1-2.
3. 3 Varshney, P., Jones, S.M., Scurlock, A.M., Perry, T.T., Kemper, A., Steele, P., et al. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol 127 (2011), 654–660.
4. 4 Anagnostou, K., Islam, S., King, Y., Foley, L., Pasea, L., Bond, S., et al. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial. Lancet 383 (2014), 1297–1304.
5. 5 Narisety, S.D., Frischmeyer-Guerrerio, P.A., Keet, C.A., Gorelik, M., Schroeder, J., Hamilton, R.G., et al. A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy. J Allergy Clin Immunol 135 (2015), 1275–1282 e1-6.
6. 6 Bird, J., Spergel, J., Jones, S., Rachid, R., Assa'ad, A., Wang, J., et al. A novel characterized peanut allergen formulation (AR101) for oral immunotherapy (OIT) induces desensitization in peanut-allergic subjects: a phase 2 clinical safety and efficacy study. Allergy, 70, 2015, 110.
7. 7 Keet, C.A., Wood, R.A., Emerging therapies for food allergy. J Clin Investig 124 (2014), 1880–1886.
8. 8 Vickery, B.P., Scurlock, A.M., Kulis, M., Steele, P.H., Kamilaris, J., Berglund, J.P., et al. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol 133 (2014), 468–475.
9. 9 Sicherer, S.H., Wood, R.A., Stablein, D., Burks, A.W., Liu, A.H., Jones, S.M., et al. Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy. J Allergy Clin Immunol 125 (2010), 1077–1083.e8.
10. 10 Du Toit, G., Roberts, G., Sayre, P.H., Plaut, M., Bahnson, H.T., Mitchell, H., et al. Identifying infants at high risk of peanut allergy: the Learning Early About Peanut Allergy (LEAP) screening study. J Allergy Clin Immunol 131 (2013), 135–143 e1-12.
11. 11 Rowe, J., Kusel, M., Holt, B.J., Suriyaarachchi, D., Serralha, M., Hollams, E., et al. Prenatal versus postnatal sensitization to environmental allergens in a high-risk birth cohort. J Allergy Clin Immunol 119 (2007), 1164–1173.
12. 12 Datta, S., Milner, J.D., Altered T-cell receptor signaling in the pathogenesis of allergic disease. J Allergy Clin Immunol 127 (2011), 351–354.
13. 13 Holt, P.G., Rowe, J., Kusel, M., Parsons, F., Hollams, E.M., Bosco, A., et al. Toward improved prediction of risk for atopy and asthma among preschoolers: a prospective cohort study. J Allergy Clin Immunol 125 (2010), 653–659 659.e1-9.e7.
14. 14 Rothers, J., Halonen, M., Stern, D.A., Lohman, I.C., Mobley, S., Spangenberg, A., et al. Adaptive cytokine production in early life differentially predicts total IgE levels and asthma through age 5 years. J Allergy Clin Immunol 128 (2011), 397–402.e2.
15. 15 Ho, M.H., Wong, W.H., Heine, R.G., Hosking, C.S., Hill, D.J., Allen, K.J., Early clinical predictors of remission of peanut allergy in children. J Allergy Clin Immunol 121 (2008), 731–736.
16. 16 Neuman-Sunshine, D.L., Eckman, J.A., Keet, C.A., Matsui, E.C., Peng, R.D., Lenehan, P.J., et al. The natural history of persistent peanut allergy. Ann Allergy Asthma Immunol 108 (2012), 326–331.e3.
17. 17 Mucosal immunotherapy for peanut allergy in young children (DEVIL). Available at: clinicaltrials.gov/ct2/show/NCT00932828. Accessed January 22, 2016.
18. 18 Boyce, J.A., Assa'ad, A., Burks, A.W., Jones, S.M., Sampson, H.A., Wood, R.A., et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol 126 (2010), S1–S58.
19. 19 Jones, S.M., Pons, L., Roberts, J.L., Scurlock, A.M., Perry, T.T., Kulis, M., et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 124 (2009), 292–300 e1-97.
20. 20 Thyagarajan, A., Jones, S.M., Calatroni, A., Pons, L., Kulis, M., Woo, C.S., et al. Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children. Clin Exp Allergy 42 (2012), 1197–1205.
21. 21 Yan, J., Fine, J., Estimating equations for association structures. Stat Med 23 (2004), 859–874 discussion 75-7, 79-80.
22. 22 Nowak-Wegrzyn, A., Assa'ad, A.H., Bahna, S.L., Bock, S.A., Sicherer, S.H., Teuber, S.S., et al. Work Group report: oral food challenge testing. J Allergy Clin Immunol 123 (2009), S365–S383.
23. 23 Perry, T.T., Matsui, E.C., Kay Conover-Walker, M., Wood, R.A., The relationship of allergen-specific IgE levels and oral food challenge outcome. J Allergy Clin Immunol 114 (2004), 144–149.
24. 24 Peters, R.L., Allen, K.J., Dharmage, S.C., Koplin, J.J., Dang, T., Tilbrook, K.P., et al. Natural history of peanut allergy and predictors of resolution in the first 4 years of life: a population-based assessment. J Allergy Clin Immunol 135 (2015), 1257–1266.e2.
25. 25 Sampson, H.A., Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol 107 (2001), 891–896.
26. 26 Lucendo, A.J., Arias, A., Tenias, J.M., Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis. Ann Allergy Asthma Immunol 113 (2014), 624–629.
27. 27 Burks, A.W., Jones, S.M., Wood, R.A., Fleischer, D.M., Sicherer, S.H., Lindblad, R.W., et al. Oral immunotherapy for treatment of egg allergy in children. N Engl J Med 367 (2012), 233–243.
28. 28 Gorelik, M., Narisety, S.D., Guerrerio, A.L., Chichester, K.L., Keet, C.A., Bieneman, A.P., et al. Suppression of the immunologic response to peanut during immunotherapy is often transient. J Allergy Clin Immunol 135 (2015), 1283–1292.
29. 29 Fleischer, D.M., Conover-Walker, M.K., Christie, L., Burks, A.W., Wood, R.A., The natural progression of peanut allergy: resolution and the possibility of recurrence. J Allergy Clin Immunol 112 (2003), 183–189.
30. 30 Tang, M.L., Ponsonby, A.L., Orsini, F., Tey, D., Robinson, M., Su, E.L., et al. Administration of a probiotic with peanut oral immunotherapy: a randomized trial. J Allergy Clin Immunol 135 (2015), 737–744.e8.
31. 31 Skolnick, H.S., Conover-Walker, M.K., Koerner, C.B., Sampson, H.A., Burks, W., Wood, R.A., The natural history of peanut allergy. J Allergy Clin Immunol 107 (2001), 367–374.
32. 32 Du Toit, G., Roberts, G., Sayre, P.H., Bahnson, H.T., Radulovic, S., Santos, A.F., et al. Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med 372 (2015), 803–813.
33. 33 Venter, C., Pereira, B., Voigt, K., Grundy, J., Clayton, C.B., Gant, C., et al. Comparison of open and double-blind placebo-controlled food challenges in diagnosis of food hypersensitivity amongst children. J Hum Nutr Diet 20 (2007), 565–579.
34. 34 Fleischer, D.M., Sicherer, S., Greenhawt, M., Campbell, D., Chan, E., Muraro, A., et al. Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants. J Allergy Clin Immunol 136 (2015), 258–261.
35. 35 Peanut oral immunotherapy in children (IMPACT). Available at: clinicaltrials.gov/ct2/show/NCT01867671. Accessed January 22, 2016.
36. Varshney, P., Steele, P.H., Vickery, B.P., Bird, J.A., Thyagarajan, A., Scurlock, A.M., et al. Adverse reactions during peanut oral immunotherapy home dosing. J Allergy Clin Immunol 124 (2009), 1351–1352.
37. Thyagarajan, A., Jones, S.M., Calatroni, A., Pons, L., Kulis, M., Woo, C.S., et al. Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children. Clin Exp Allergy 42 (2012), 1197–1205.
38. Vickery, B.P., Scurlock, A.M., Kulis, M., Steele, P.H., Kamilaris, J., Berglund, J.P., et al. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol 133 (2014), 468–475.
39. Skripak, J.M., Matsui, E.C., Mudd, K., Wood, R.A., The natural history of IgE-mediated cow's milk allergy. J Allergy Clin Immunol 120 (2007), 1172–1177.
40. Savage, J.H., Matsui, E.C., Skripak, J.M., Wood, R.A., The natural history of egg allergy. J Allergy Clin Immunol 120 (2007), 1413–1417.
41. Savage, J.H., Limb, S.L., Brereton, N.H., Wood, R.A., The natural history of peanut allergy: extending our knowledge beyond childhood. J Allergy Clin Immunol 120 (2007), 717–719.
42. Savage, J.H., Kaeding, A.J., Matsui, E.C., Wood, R.A., The natural history of soy allergy. J Allergy Clin Immunol 125 (2010), 683–686.
43. Skolnick, H.S., Conover-Walker, M.K., Koerner, C.B., Sampson, H.A., Burks, W., Wood, R.A., The natural history of peanut allergy. J Allergy Clin Immunol 107 (2001), 367–374.